Pacira BioSciences Inc — Balance Sheet (NASDAQ:PCRX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 1.27 B2.08 B1.68 B1.57 B1.55 B1.26 B Total liabilities 654.83 M1.34 B906.19 M704.26 M775.17 M571.81 M Total equity 619.69 M730.41 M775.01 M870.13 M778.35 M693.11 M Total liabilities & shareholders' equities 1.27 B2.08 B1.68 B1.57 B1.55 B1.26 B Total debt —————— Net debt ——————

Haberler

Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Pacira kazancı $0,33 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Pacira’nın kazançları yaklaşırken EXPAREL jenerik tehdidiyle karşı karşıya

Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)

Pacira BioSciences Kıdemli Başkan Yardımcısı Lauren Riker 83 bin dolarlık hisse satışı gerçekleştirdi

Pacira BioSciences SVP Lauren Riker sells $83k in stock

Pacira BioSciences officer Williams sells $269k in shares

5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates

Pacira BioSciences appoints Samit Hirawat to board of directors

Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why

Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?